Lung Cancer

Top Story

SBRT offers treatment option for elderly patients with lung cancer

SBRT offers treatment option for elderly patients with lung cancer
March 23, 2017

Stereotactic body radiotherapy was safe and effective for elderly patients with early-stage lung cancer, according to results of a retrospective analysis presented at the Multidisciplinary Thoracic Cancers Symposium.

“As the cancer community ages and more patients in their 80s and 90s will present with lung cancer — in addition to the more widespread use of low-dose CT screening, which will increase the number of diagnoses of early-stage lung cancer patients — we need to understand more about which of these patients can safely be treated, and if there is actually a role for definitive [stereotactic body radiation therapy] in this population,” Richard J. Cassidy III, MD, resident in radiation oncology at Emory University’s Winship Cancer Institute, said during a press conference.

In the Journals Plus

Younger age associated with genetic alterations in lung adenocarcinoma

March 22, 2017
Oncogenic genetic alterations occurred more frequently among patients aged younger than 40 years with lung adenocarcinoma than older patients, according to results of a…

‘We can do better’: ASCO report outlines persistent health care disparities, need for funding

March 22, 2017
Over the next 10 years, the number of cancer survivors in the United States is expected to grow from 15.5 million to 20.3 million, according to ASCO’s State of
Meeting News

Poor outcomes more common among minority populations with NSCLC

March 21, 2017
Black and American Indian patients with stage I non–small cell lung cancer had higher rates of overall and cancer-specific mortality than white patients, a…
CME

Immuno-Oncology Forum: Focus on Non-Small Cell Lung Cancer

This activity is supported by educational grants from Bristol-Myers Squibb; Genentech, Inc.; and Merck & Co., Inc.

Lung cancer accounts for 27% of all cancer deaths in the United States, making it the leading cause of cancer…
More »
Video
Meeting News Coverage

VIDEO: Merge of immunotherapy, genomics leads to personalized treatment

June 23, 2016
More »
Featured
HEMONC TODAY Melanoma and Cutaneous Malignancies

HEMONC TODAY Melanoma and Cutaneous Malignancies

In the Journals PlusAbstract Only

Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non–Small Cell Lung Cancer

March 23, 2017
AUTHORS:
Anagnostou V, et al.

Meeting News

SBRT offers treatment option for elderly patients with lung cancer

March 23, 2017
Stereotactic body radiotherapy was safe and effective for elderly patients with early-stage lung cancer, according to results of a retrospective…

In the Journals Plus

Younger age associated with genetic alterations in lung adenocarcinoma

March 22, 2017
Oncogenic genetic alterations occurred more frequently among patients aged younger than 40 years with lung adenocarcinoma than older patients…

‘We can do better’: ASCO report outlines persistent health care disparities, need for funding

March 22, 2017
Over the next 10 years, the number of cancer survivors in the United States is expected to grow from 15.5 million to 20.3 million, according to…

Meeting News

Poor outcomes more common among minority populations with NSCLC

March 21, 2017
Black and American Indian patients with stage I non–small cell lung cancer had higher rates of overall and cancer-specific mortality than white…

Meeting NewsPerspective

Circulating tumor cell test can detect lung cancer recurrence before CT

March 21, 2017
Blood tests that used circulating tumor cells as biomarkers detected recurrences of locally advanced non–small cell lung cancer months earlier…

Meeting NewsPerspective

Proton therapy shows promise for recurrent lung cancer

March 20, 2017
Intensity-modulated proton therapy conferred durable control with minimal toxicity among patients with recurrent thoracic cancer, according to…

In the Journals

Cancer surveillance guidelines lack specificity, consistency

March 20, 2017
Recommendations for surveillance after cancer treatment in survivors across guidelines are often nonspecific and inconsistent; therefore…

Meeting NewsPerspective

Radiation prior to immune checkpoint inhibitor therapy may lower toxicity

March 20, 2017
Ten percent of patients with lung cancer who received thoracic radiation therapy with immune checkpoint inhibitors experienced severe toxicities…

Meeting NewsPerspective

Multiple biopsies may help identify, treat resistance in NSCLC

March 17, 2017
More than one in five patients with non–small cell lung cancer develop various types of genetic resistance during treatment and could benefit…

More Headlines »
Advertisement
Advertisement